Established In 1996Tianjin Chasesun Pharmaceutical Co Ltdis A High Tech Medicineand Health Industry Group Engaged In Such Fields As Chineseherb Preparationchinesemedicinal Granulesynthetic Drugsbiotech Drugsmedical Apparatus And Internet Based Therapyand Integrating Investmentresearch And Developmentproduction And Capital Adhering To Its Concept Of All Round Innovationchasesun Has Established Thefirst Technology Transformation Center And Academician Work Station In Tianjinworked With Scientific Research Institutions To Establish Theinnovation Alliancewith Enterprises As Thecoreand Developed A Trump Card Series Of Products With Independent Intellectual Property Rights Represented Byxuebijinginjectioneiea A Ea Andfull Compositionformula Granulesa Ae Aanow Chasesun Owns 142 Domestic Invention Patents In Effect159 Domestic Utility Model Patents In Effectand Two International Invention Patents In Effect Takingtheinheritor Of Chinesemedicineand Theleader Of Health Industryfor Thevisionchasesun Has Achieved Multi Dimensional Leaps And Bounds Through A Variety Of Financing Instrumentsestablishing Industry Clusters In Many Fields Including Raw Materials Productionchineseherbal Medicineplantingmodernized Tcm Preparationtcm Formula Granulessynthetic Drugsbiotech Drugsmedical Apparatuswearablemedical Productsand Internet Based Therapychasesun Has Developed Into A Medicineand Health Industry Group Integrating Investment And Financingresearch And Developmentand Production And Sales Chasesun Achieved Sales Revenueof Rmb 48 Billion In 2015And Paid Taxation Amounting Rmb 6 000 000By Thebeginning Of 2016Chasesun Has Total Assets Valued At Rmb 6 4 Billion And A Market Valueof Rmb 20 Billionwith 29 Subordinatecompanies And Morethan 5 400 Employees
